Skip to main content

1Provenance card

the boundary, as counts

Sources

3925 with DOI

7 strong · 25 moderate · 7 weak

Compilations

22026-05-12T21:56:24.090Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

30last ruled 2026-06-04

0 awaiting a ruling

Issued documents

42026-10-19T20:30:26.651Z

notice · info card · emergency

Searches

00 with no results

queries and counts on the build

Claims checked

8667 supported

67 supported · 19 not

Correspondence

0received

consent field ships in Phase 4

Edges

254

derivations recorded for this entity

Complete over 39 sources, 2 compilations, and 30 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/adrafinil/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued info_card
  2. 2026-09-07srcEffects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.
  3. 2026-09-07srcEnantioselective separation and determination of adrafinil and modafinil on Chiralcel OJ-H column in rat serum and urine using solid-phase extraction followed by HPLC.
  4. 2026-09-07srcDevelopment of a validated LC method for enantiomeric separation and determination of adrafinil and its related substances on a Chiralcel OJ-H column.
  5. 2026-09-07srcOutsmarted by nootropics? An investigation into the thermal degradation of modafinil, modafinic acid, adrafinil, CRL-40,940 and CRL-40,941 in the GC injector.
  6. 2026-09-07srcLC-MS of novel narcoepileptics and related substances.
  7. 2026-09-07srcAdrafinil-induced orofacial dyskinesia.
  8. 2026-09-07srcDoping control analysis for adrafinil and its major metabolites in human urine.
  9. 2026-09-07srcModafinil, an atypical CNS stimulant?
  10. 2026-09-07srcA positron emission tomography study examining the dopaminergic activity of armodafinil in adults using [11C]altropane and [11C]raclopride.
  11. 2026-09-07srcCardiovascular stimulant actions of bupropion in comparison to cocaine in the rat.
  12. 2026-09-07srcModafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review.
  13. 2026-09-07srcHow effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine
  14. 2026-09-07srcLC-ESI-MS determination and pharmacokinetics of adrafinil in rats.
  15. 2026-09-07srcElectrophysiological and amperometric evidence that modafinil blocks the dopamine uptake transporter to induce behavioral activation.
  16. 2026-09-07srcModafinil: its discovery, the early European and North American experience in the treatment of narcolepsy and idiopathic hypersomnia, and its subsequent use in other medical conditions.
  17. 2026-09-07srcPharmacokinetic and pharmacodynamic of the cognitive enhancer modafinil: Relevant clinical and forensic aspects.
  18. 2026-09-07srcDevelopment and Validation of an Analytical Method to Identify and Quantitate Novel Modafinil Analogs in Products Marketed as Dietary Supplements.
  19. 2026-09-07srcIdentification of adrafinil and its main metabolite modafinil in human hair. Self-administration study and interpretation of an authentic case.
  20. 2026-09-07srcSleep medicine, sleep research, and sleep education: a whole life devoted to sleep.
  21. 2026-09-07srcAdrafinil: A Novel Vigilance Promoting Agent
  22. 2026-09-07srcThe role of eugeroics in the treatment of affective disorders.
  23. 2026-09-07srcFunctional neuroanatomy of dopaminergic arousal systems: implications for the wake-promoting effect of psychostimulants, with particular reference to modafinil.
  24. 2026-09-07srcThe Psychonauts' World of Cognitive Enhancers
  25. 2026-09-07srcModafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
  26. 2026-09-07srcA novel study of screening and confirmation of modafinil, adrafinil and their metabolite modafinilic acid under EI-GC-MS and ESI-LC-MS-MS ionization.
  27. 2026-09-07srcIn vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.
  28. 2026-09-07srcAdrafinil: effects on behavior and cognition in aged canines.
  29. 2026-09-07srcIncreased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants.
  30. 2026-09-07srcEffect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers.
  31. 2026-09-07srcClinical pharmacokinetic profile of modafinil.
  32. 2026-09-07srcWhat keeps us awake: the neuropharmacology of stimulants and wakefulness-promoting medications.
  33. 2026-09-07srcInfluence of alpha stimulants and beta blockers on yohimbine toxicity.
  34. 2026-09-07srcSingle-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers.
  35. 2026-09-07srcAdrafinil - Wikipedia
  36. 2026-09-07srcPubChem Compound: Adrafinil (CID 3033226)
  37. 2026-09-07srcNCATS Inxight Drugs: Adrafinil (BI81Z4542G)
  38. 2026-09-07srcChemicalBook: Adrafinil (CAS 63547-13-7) Physical Properties
  39. 2026-09-07srcWADA Prohibited List 2025 - S6 Stimulants category
  40. 2026-09-07srcModafinil/Armodafinil - LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
  41. 2026-09-04issueIssued emergency
  42. 2026-09-04issueIssued info_card
  43. 2026-09-04issueIssued notice
  44. 2026-06-04proposal28 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  45. 2026-06-04publicationPublication — backfill
  46. 2026-05-12revisionRevision 1
  47. 2026-05-12genGeneration — pipeline-v5 · with 3 morepipeline-v5
  48. 2026-05-12rungeneration run
  49. 2026-05-11rungeneration run

The same entries, as forms: six forms.